Cardiologists and pharmacy leaders explained how team-based clinics and standardized paperwork are speeding obstructive HCM ...
The FDA has approved secukinumab for PMR after the REPLENISH trial showed doubled sustained remission and lower steroid use vs a steroid taper alone.
San Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy ...
Nearly 90% of patients in the MINT trial tapered prednisone to 5 mg/day or less, with no significant safety concerns seen to ...
In this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
FDA grants accelerated approval to neladalkib for previously treated locally advanced or metastatic ALK-positive non-small ...
Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics.
IL-23 inhibitors linked to lower psoriatic arthritis risk than JAK inhibitors, and IL-17 inhibitors showed higher risk.
Once weekly tirzepatide significantly reduces body mass index in adolescents with obesity compared with placebo.
Rural patients with HFrEF had lower mortality when treated at urban hospitals but higher early mortality than urban patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results